Lines of Operation

Partnering with Teva

Asking, Thinking, Discovering

Teva nurtures pharmaceutical progress through partnership

Asking questions, thinking about things from a different angle and discovering new possibilities are at the heart of progress. Teva seeks to partner with companies at all stages of the pharmaceutical development.
 
Through partnerships, Teva offers smaller companies and academic institutions access to its reputable assets and resources:
 
  • Proven success s in developing proprietary therapies
  • Genuine commitment to projects that are selected for partnership
  • Reliance on external research & partnering to obtain products for development
  • Unmatched deal flexibility for creating a win-win situation, for both Teva and our partners

 

Teva Innovative Ventures (TIV)

Teva Innovative Ventures (TIV) nurtures pharmaceutical progress by operating a global sourcing program that invests in companies with promising products and technologies at the drug discovery phase.

We seek products that:

  • Answer high unmet clinical needs
  • Constitute new chemical/biological entities
  • Show proof of efficacy in relevant animal models
  • Have potential advantages over existing therapeutics
  • Own exclusive intellectual property rights
 
Our Acceptance Process
Teva runs a 4 stage acceptance process:
 
  • Initial screening of non-confidential information
  • Full product package review
  • Validation testing and business negotiations
  • Full pre-clinical/clinical development and standard FDA and EMA regulatory testing